Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Evaluating saline irrigation for treating retained pleural infections

Official title: Evaluating the Efficacy and Safety of Saline Irrigation as an Add-On Therapy for Retained Pleural Infections (LYTICS +)

Run by Beth Israel Deaconess Medical Center · NCT06713382 · Data updated 2026-11-12

This study is testing if adding saline irrigation to standard treatment can help people with retained pleural infections feel better and recover faster.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment96 (estimated)
SponsorBeth Israel Deaconess Medical Center
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedApril 10, 2025
Main results expectedNovember 20, 2026
Study endsJanuary 20, 2027
Registry record updatedAugust 28, 2026
Trial IDNCT06713382 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with purulent pleural fluid or specific biochemical markers indicating severe pleural infection.

Probably not a fit

Patients with significant comorbidities, pregnant individuals, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot clinical trial aims to assess the efficacy and safety of saline irrigation as an adjunct therapy for patients with retained pleural infections. It involves a two-arm design where one group receives standard care, including antibiotics and chest tube placement, while the other group receives saline irrigation in addition to standard care. The study will measure outcomes such as the reduction in pleural effusion volume using imaging techniques. The hypothesis is that saline irrigation could enhance the effectiveness of intrapleural fibrinolytic therapy in these patients.

Why it matters

Potential benefit: If successful, this approach could improve treatment outcomes for patients with persistent pleural infections.

How similar studies have gone: While the use of saline irrigation in this context is novel, other studies have explored similar adjunct therapies with varying degrees of success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Presence of purulent pleural fluid or pleural fluid analysis with any of the following:
* pH ≤ 7.2.
* Glucose \< 40 mg/dL.
* LDH \> 1000 IU/L.
* Presence of bacterial or fungal organisms on Gram stain or culture.
* Chest tube placement with less than 200 mL drainage in 24 hours.
* Indication for IPFT treatment based on treating physician's criteria.
* Radiographic evidence of septations on chest ultrasound (US) or loculations on low-dose chest computed tomography (CT).

Exclusion Criteria:

* Inability to provide informed consent.
* Pregnant patients.
* Patients with significant comorbidities that may interfere with the study -outcomes (e.g., terminal malignancy).
* Complicated sympathetic effusion.
* Hepatic hydrothorax.

Where it's running

  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.